Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 273, Issue 1-2, 2008, Pages 67-69

  Zetterberg, Henrik ^a   Jacobsson, Johan ^b   Rosengren, Lars ^a   Blennow, Kaj ^a   Andersen, Peter M ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age at onset; Amyotrophic lateral sclerosis; Apolipoprotein E; SOD1

Indexed keywords

APOLIPOPROTEIN E; RILUZOLE;

ADULT; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; APOLIPOPROTEIN E4; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS;

EID: 50049096429     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.06.025     Document Type: Article

References (25)

1. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 6 (2006) 37-46
2. Jellinger K.A. Head injury and dementia. Curr Opin Neurol 17 (2004) 719-723
3. Jordan B.D., Relkin N.R., Ravdin L.D., Jacobs A.R., Bennett A., and Gandy S. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. Jama 278 (1997) 136-140
4. Koponen S., Taiminen T., Kairisto V., Portin R., Isoniemi H., Hinkka S., et al. APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injury. Neurology 63 (2004) 749-750
5. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342 (1993) 697-699
6. Waters R.J., and Nicoll J.A. Genetic influences on outcome following acute neurological insults. Curr Opin Crit Care 11 (2005) 105-110
7. Bedlack R.S., Strittmatter W.J., and Morgenlander J.C. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol 57 (2000) 1561-1565
8. Mui S., Rebeck G.W., McKenna-Yasek D., Hyman B.T., and Brown Jr. R.H. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 38 (1995) 460-463
9. Siddique T., Pericak-Vance M.A., Caliendo J., Hong S.T., Hung W.Y., Kaplan J., et al. Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis. Neurogenetics 1 (1998) 213-216
10. Moulard B., Sefiani A., Laamri A., Malafosse A., and Camu W. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis. J Neurol Sci 139 Suppl (1996) 34-37
11. Drory V.E., Birnbaum M., Korczyn A.D., and Chapman J. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci 190 (2001) 17-20
12. Li Y.J., Pericak-Vance M.A., Haines J.L., Siddique N., McKenna-Yasek D., Hung W.Y., et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 5 (2004) 209-213
13. Zetterberg H., Jacobsson J., Rosengren L., Blennow K., and Andersen P.M. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur J Neurol 14 (2007) 1329-1333
14. Andersen P.M., Borasio G.D., Dengler R., Hardiman O., Kollewe K., Leigh P.N., et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 12 (2005) 921-938
15. Zetterberg M., Landgren S., Andersson M.E., Palmer M.S., Gustafson D.R., Skoog I., et al. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (Dec 28, 2007) [Electronioc publication ahead of print]
16. Blennow K., Ricksten A., Prince J.A., Brookes A.J., Emahazion T., Wasslavik C., et al. No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J Neural Transm 107 (2000) 1065-1079
17. Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.L., Tarvainen I., Haltia T., et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 10 (1995) 61-66
18. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 38 4 (2006) 411-413
19. Prince J.A., Zetterberg H., Andreasen N., Marcusson J., and Blennow K. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 62 (2004) 2116-2118
20. Altman D.G. Practical statistics for medical research. 1st ed (1991), Chapman & Hall/CRC, London
21. Farrer L.A., Abraham C.R., Volicer L., Foley E.J., Kowall N.W., McKee A.C., et al. Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp Neurol 136 (1995) 162-170
22. Zareparsi S., Camicioli R., Sexton G., Bird T., Swanson P., Kaye J., et al. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 107 (2002) 156-161
23. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
24. Pericak-Vance M.A., St George-Hyslop P.H., Gaskell Jr. P.C., Growdon J., Crain B.J., Hulette C., et al. Linkage analysis in familial Alzheimer disease: description of the Duke and Boston data sets. Genet Epidemiol 10 (1993) 361-364
25. Van Broeckhoven C., Backhovens H., Cruts M., Martin J.J., Crook R., Houlden H., et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 169 (1994) 179-180